Adero Partners’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $56.5K | Hold |
12,477
| – | – | ﹤0.01% | 255 |
|
|
2024
Q4 | $88.2K | Hold |
12,477
| – | – | 0.01% | 252 |
|
|
2024
Q3 | $102K | Hold |
12,477
| – | – | 0.01% | 231 |
|
|
2024
Q2 | $79.7K | Hold |
12,477
| – | – | 0.01% | 211 |
|
|
2024
Q1 | $94K | Hold |
12,477
| – | – | 0.01% | 194 |
|
|
2023
Q4 | $116K | Hold |
12,477
| – | – | 0.01% | 183 |
|
|
2023
Q3 | $126K | Hold |
12,477
| – | – | 0.01% | 171 |
|
|
2023
Q2 | $156K | Hold |
12,477
| – | – | 0.02% | 159 |
|
|
2023
Q1 | $146K | Hold |
12,477
| – | – | 0.02% | 156 |
|
|
2022
Q4 | $133K | Hold |
12,477
| – | – | 0.02% | 156 |
|
|
2022
Q3 | $110K | Hold |
12,477
| – | – | 0.01% | 150 |
|
|
2022
Q2 | $197K | Hold |
12,477
| – | – | 0.03% | 145 |
|
|
2022
Q1 | $326K | Hold |
12,477
| – | – | 0.05% | 119 |
|
|
2021
Q4 | $494K | Buy |
+12,477
| New | +$494K | 0.08% | 96 |
|